- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04766255
Behavioral Comparison of Three Different Graft Materials to Increase Soft Tissue Thickness Around Dental Implants.
Behavioral Comparison of Three Different Graft Materials to Increase Soft Tissue Thickness Around Dental Implants in Terms of Volume Gain and Stability Over Time: A Randomized Clinical Trial.
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Phase 4
Contacts and Locations
Study Contact
- Name: Andres Pascual La Rocca, DDS
- Phone Number: 0034627725044
- Email: pascuallarocca@hotmail.com
Study Contact Backup
- Name: Cristina Valles Vega, DDS
- Phone Number: 0034627725044
- Email: cristinavallveg@hotmail.com
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Patients referred to Department of Periodontology (CUO) in need of a single implant and need of soft tissue augmentation such as buccal defects, thin biotype, lack of keratinized tissue and aesthetic compromised situation.
- The patient must be ≥18 years and able to understand the nature of the proposed surgery and must sign an informed consent.
- The implant must be located between 2 fixed reference points (i.e. clinical crowns).
- Anterior and premolar teeth (from premolar to premolar).
- Enough crestal bone width to leave a minimum thickness of 2mm at the buccal bone plate when placing the implant.
- Palate must have ≥2mm of thickness at premolar area.
- Full mouth plaque and bleeding score <20%.
Exclusion Criteria:
- Pregnant or lactation.
- Active periodontal disease.
- Previous soft tissue augmentation in the area.
- Need of guided bone regeneration (GBR) during or after the placement of the implant.
- Heavy smokers (> 10 cigarettes per day).
- Local or systemic conditions that would interfere with routine periodontal therapy (non-controlled diabetes mellitus, cancer, HIV, Chronic High dose steroid therapy, bone metabolic diseases, radiation, immunosuppressive disorders, liver function disorder, immunosuppressant disease, autoimmune disease).
- Allergy to non-steroidal anti-inflammatory drugs.
- Patients taking medications that cause gingival enlargement.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Control Group
Implant placement and prosthetic rehabilitation of the missing tooth
|
A crestal incision will be made in the implant reception area, extending from the distal of the most mesial tooth to the mesial of the most distal tooth.
A mucoperiosteal flap will be elevated in the most crestal part of the ridge.
The receptor bed will be prepared following the established drilling protocol for the placement of a BioHorizons Tapered Pro Implant (Biohorizons, Birmingham AL).
The diameter and length of the implant will be previously established during the implant study.
Later a healing abutment will be placed.
|
Experimental: SCTG group
Implant placement, soft tissue augumentation of Connective Tissue Graft (from the palate) (SCTG) at the implant site and prosthetic rehabilitation of the missing tooth.
|
A crestal incision will be made in the implant reception area, extending from the distal of the most mesial tooth to the mesial of the most distal tooth.
A mucoperiosteal flap will be elevated in the most crestal part of the ridge.
The receptor bed will be prepared following the established drilling protocol for the placement of a BioHorizons Tapered Pro Implant (Biohorizons, Birmingham AL).
The diameter and length of the implant will be previously established during the implant study.
Later a healing abutment will be placed.
Donor site: SCTG group: The SCTG will be harvested in the palat,In order to extract the same thickness in each grafts a double-bladed knife (separated by 1,5mm) will be used. The donor area will be sutured. Recipient site: SCTG group: the connective tissue graft will be trimmed to the correct dimensions (10mm height, 12mm length and 1,5mm thick) and placed and secured at the recipient site with a resorbable 5-0 suture CM group: The CM graft (Geistlich Fibro-gide) will be trimmed to the indicated dimensions (10mm height, 12mm length) and placed and secured at the recipient site with resorbable 5-0 suture PADM Group: the ADM (NovoMatrix, Biohorizons, Birmingham AL) graft will be trimmed to the indicated dimensions (10mm height, 12mm length) and placed and secured at the recipient site with resorbable 5-0 suture |
Experimental: CM group
Implant placement, soft tissue augumentation of porcine collagen matrix (CM) at the implant site and prosthetic rehabilitation of the missing tooth.
|
A crestal incision will be made in the implant reception area, extending from the distal of the most mesial tooth to the mesial of the most distal tooth.
A mucoperiosteal flap will be elevated in the most crestal part of the ridge.
The receptor bed will be prepared following the established drilling protocol for the placement of a BioHorizons Tapered Pro Implant (Biohorizons, Birmingham AL).
The diameter and length of the implant will be previously established during the implant study.
Later a healing abutment will be placed.
Donor site: SCTG group: The SCTG will be harvested in the palat,In order to extract the same thickness in each grafts a double-bladed knife (separated by 1,5mm) will be used. The donor area will be sutured. Recipient site: SCTG group: the connective tissue graft will be trimmed to the correct dimensions (10mm height, 12mm length and 1,5mm thick) and placed and secured at the recipient site with a resorbable 5-0 suture CM group: The CM graft (Geistlich Fibro-gide) will be trimmed to the indicated dimensions (10mm height, 12mm length) and placed and secured at the recipient site with resorbable 5-0 suture PADM Group: the ADM (NovoMatrix, Biohorizons, Birmingham AL) graft will be trimmed to the indicated dimensions (10mm height, 12mm length) and placed and secured at the recipient site with resorbable 5-0 suture |
Experimental: PADM group
Implant placement, soft tissue augumentation of Porcine acellular dermal matrix (PADM) at the implant site and prosthetic rehabilitation of the missing tooth.
|
A crestal incision will be made in the implant reception area, extending from the distal of the most mesial tooth to the mesial of the most distal tooth.
A mucoperiosteal flap will be elevated in the most crestal part of the ridge.
The receptor bed will be prepared following the established drilling protocol for the placement of a BioHorizons Tapered Pro Implant (Biohorizons, Birmingham AL).
The diameter and length of the implant will be previously established during the implant study.
Later a healing abutment will be placed.
Donor site: SCTG group: The SCTG will be harvested in the palat,In order to extract the same thickness in each grafts a double-bladed knife (separated by 1,5mm) will be used. The donor area will be sutured. Recipient site: SCTG group: the connective tissue graft will be trimmed to the correct dimensions (10mm height, 12mm length and 1,5mm thick) and placed and secured at the recipient site with a resorbable 5-0 suture CM group: The CM graft (Geistlich Fibro-gide) will be trimmed to the indicated dimensions (10mm height, 12mm length) and placed and secured at the recipient site with resorbable 5-0 suture PADM Group: the ADM (NovoMatrix, Biohorizons, Birmingham AL) graft will be trimmed to the indicated dimensions (10mm height, 12mm length) and placed and secured at the recipient site with resorbable 5-0 suture |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
soft tissue volume gain
Time Frame: after 3 months
|
Optical scans superposition
|
after 3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
soft tissue volume stability
Time Frame: after 15 months
|
Optical scans superposition
|
after 15 months
|
Plaque index (PI)
Time Frame: at baseline, after 12 weeks and after 15 months.
|
Each tooth will be divided in 4 surfaces: buccal, lingual, mesial, distal.
After the application of erythrosine, O'Leary plaque index will be registered (O'Leary et al. 1972)
|
at baseline, after 12 weeks and after 15 months.
|
Bleeding on probing (BI)
Time Frame: at baseline, after 12 weeks and after 15 months.
|
Each tooth will be divided in 4 surfaces: buccal, lingual, mesial, distal.
After a gentle probing if the gingiva bleeds will be positive.
|
at baseline, after 12 weeks and after 15 months.
|
Probing depth (PD)
Time Frame: at baseline, after 12 weeks and after 15 months.
|
in the implant area (implant and both tooth next to it).
Distance from the gingival margin to the bottom of the gingival sulcus using periodontal probe (UNC 15).
Measured in 6 points: mesiobuccal, buccal, distobuccal, mesiolingual, lingual and distolingual.
|
at baseline, after 12 weeks and after 15 months.
|
Width of keratinized tissue (KT)
Time Frame: at baseline, after 12 weeks and after 15 months.
|
in the implant area (implant and both teeth nxt to it).
Measured in the medial buccal point of the tooth/implant.
Distance from mucogingival junction to the most apical portion of the crest of the marginal gingiva.
The mucogingival junction will be identified by the roll technique, wherein the mucosa is rolled until the non-movable portion of the attached keratinized tissue is seen
|
at baseline, after 12 weeks and after 15 months.
|
Phenotype evaluation (PT)
Time Frame: at baseline, after 12 weeks and after 15 months.
|
the gingival biotype was categorized as thin or thick based on the transparency of a periodontal probe (CP15 UNC; Hu-Friedy, Chicago, IL, USA) through the soft tissues while probing the buccal sulcus of the contra-lateral tooth (17-19)
|
at baseline, after 12 weeks and after 15 months.
|
Patient reported outcome measures (PROMs)
Time Frame: after the surgery procedures (baseline) and after 7 days (suture removal)
|
patient pain/discomfort will be evaluated (a questionnaire will be provided to each patient after all the surgery procedures and it will be recollected the day of suture removal)
|
after the surgery procedures (baseline) and after 7 days (suture removal)
|
Pink Esthetic Score (PES)
Time Frame: After 2 weeks of the definite crown placement (around 16 months)
|
will be registered to obtain information related to the papilla, the level of soft-tissue margin, the alveolar process, the color, contour and texture of the same soft tissue
|
After 2 weeks of the definite crown placement (around 16 months)
|
Collaborators and Investigators
Investigators
- Principal Investigator: Andres Pascual La Rocca, DDS, Universitat Internacional de Catalunya
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PER-ECL-2017-07
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Edentulous Alveolar Ridge
-
Mashhad University of Medical SciencesCompletedAtrophy of Edentulous Alveolar Ridge | Alveolar Ridge AugmentationIran, Islamic Republic of
-
Ain Shams UniversityNot yet recruitingEvaluation of Marginal Bone Loss of Two Immediately Loaded Implants Retaining Mandibular OverdentureEdentulous Alveolar RidgeEgypt
-
ARDEC AcademyUniversidad Nacional de TrujilloRecruiting
-
ahmed ashraf abdelreheemRecruiting
-
Paolo PesceCompletedEdentulous Alveolar RidgeItaly
-
University of BaghdadCompletedEdentulous Alveolar RidgeIraq
-
Fundación Eduardo AnituaBTI S.LActive, not recruitingEdentulous Alveolar RidgeSpain
-
Cairo UniversityUnknown
Clinical Trials on Implant Placement
-
University of BernNot yet recruitingComplications | Patient Reported Outcome Measures | Cost-Benefit Analysis | Cost-effectiveness | Esthetic Zone | Single Tooth Dental Implant | Single Tooth Lost | Accuracy of Dental Implants | Dimensional Changes | Implant Survival and Success | Frequency of Treatment ProtocolSwitzerland
-
Sun Yat-sen UniversityRecruitingJaw, Edentulous, Partially | Acquired Absence of Single ToothChina
-
University of CagliariRecruiting
-
Hospital General Universitario Morales MeseguerNot yet recruiting
-
Universidade Católica PortuguesaDanilo FernandesCompleted
-
Cairo UniversityCompletedAtrophic Maxillary Ridge and Mandibular RidgeEgypt
-
Cairo UniversityUnknownEdentulous Alveolar Ridge
-
Columbia UniversityCompletedGingival Recession | Bone Loss, Alveolar
-
Misr International UniversityNot yet recruiting
-
Tanta UniversityActive, not recruitingBone Loss | Dental ImplantsEgypt